Cannabinoid/endocannabinoid signaling impact on early pregnancy events

12Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.
Get full text

Abstract

It has been known for decades that marijuana and its major psychoactive component Δ9-tetrahydrocannabinol (THC) alter both male and female reproductive functions in humans and laboratory animals. The discovery of cannabinoid-like molecules (endocannabinoids), anandamide (AEA) and 2-arachidonylglycerol (2AG), as well as G-protein-coupled cannabinoid/endocannabinoid receptors CB1 and CB2, created an opportunity to study the adverse and beneficial effects of cannabinoids/endocannabinoids on fertility using molecular, physiological and genetic approaches. In fact, studies to explore the significance of cannabinoid/endocannabinoid signaling in reproduction have revealed some intriguing physiological roles in early pregnant events. This review summarizes some aspects of these signaling molecules in preimplantation and implantation biology utilizing genetically engineered mouse models. © Springer-Verlag Berlin Heidelberg 2009.

Cite

CITATION STYLE

APA

Sun, X., & Dey, S. K. (2009). Cannabinoid/endocannabinoid signaling impact on early pregnancy events. Current Topics in Behavioral Neurosciences. Springer Verlag. https://doi.org/10.1007/978-3-540-88955-7_10

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free